Department of Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland.
Behav Brain Res. 2013 Apr 15;243:6-15. doi: 10.1016/j.bbr.2012.12.051. Epub 2013 Jan 4.
Despite the widely held belief that Parkinson's disease is caused by both underlying genetics and exposure to environmental risk factors, it is still widely modelled in preclinical models using a single genetic or neurotoxic insult. This single-insult approach has resulted in a variety of models that are limited with respect to their aetiological, construct, face and/or predictive validity. Thus, the aim of the current study was to investigate the interplay between genes and the environment as an alternative approach to modelling Parkinson's disease. To do so, rats underwent stereotaxic surgery for unilateral delivery of the Parkinson's disease-associated gene, α-synuclein, into the substantia nigra (using AAV vectors). This was followed 13 weeks later by subcutaneous implantation of an osmotic minipump delivering the Parkinson's disease-associated pesticide, rotenone (2.5mgkg(-1)day(-1) for 4 weeks). The effect of the genetic and environmental insults alone or in combination on lateralised motor performance (Corridor, Stepping and Whisker Tests), nigrostriatal integrity (tyrosine hydroxylase immunohistochemistry) and α-synucleinopathy (α-synuclein immunohistochemistry) was assessed. We found that exposing AAV-α-synuclein-treated rats to rotenone led to a model in which the classical Parkinson's disease triad of progressive motor dysfunction, nigrostriatal neurodegeneration and α-synucleinopathy was evident. However, delivering rotenone systemically was also associated with bilateral motor dysfunction and loss of body weight. Thus, although we have shown that Parkinson's disease can be modelled in experimental animals by combined exposure to both genetic and environmental risk factors, this approach is limited by systemic toxicity of the pesticide rotenone. Direct intracerebral delivery of rotenone may be more useful in longer-term studies as we have previously shown that it overcomes this limitation.
尽管人们普遍认为帕金森病是由潜在的遗传因素和环境风险因素共同引起的,但在临床前模型中,它仍然主要通过单一的遗传或神经毒性损伤来建模。这种单一损伤的方法导致了多种模型的产生,这些模型在病因学、构建、表面和/或预测有效性方面都存在局限性。因此,本研究旨在探讨基因与环境之间的相互作用,作为一种替代方法来模拟帕金森病。为此,大鼠接受立体定向手术,将帕金森病相关基因α-突触核蛋白单侧递送至黑质(使用 AAV 载体)。13 周后,皮下植入可持续释放帕金森病相关农药鱼藤酮的渗透微型泵(2.5mgkg(-1)day(-1),持续 4 周)。单独或联合遗传和环境损伤对侧化运动表现(走廊、踏步和触须测试)、黑质纹状体完整性(酪氨酸羟化酶免疫组织化学)和α-突触核蛋白病(α-突触核蛋白免疫组织化学)的影响进行了评估。我们发现,将 AAV-α-突触核蛋白处理的大鼠暴露于鱼藤酮中,会导致一种模型,其中经典的帕金森病三联征,即进行性运动功能障碍、黑质纹状体神经退行性变和α-突触核蛋白病明显。然而,全身性给予鱼藤酮也与双侧运动功能障碍和体重减轻有关。因此,尽管我们已经表明,通过同时暴露于遗传和环境风险因素,帕金森病可以在实验动物中建模,但这种方法受到农药鱼藤酮的全身毒性的限制。正如我们之前所表明的那样,直接脑内给予鱼藤酮可能在长期研究中更有用,因为它克服了这一限制。